Abstract:ID 92956 Poster Board 547 The striatum is a major input to the basal ganglia. The striatum is involved with neuronal activity that is responsible for reward, movements, and connections between the two. Dysfunction in the striatum is associated with the symptoms of myriad disorders, including substance use disorder, schizophrenia, obsessive compulsive disorder, Huntington's disease, and Parkinson's disease. The dorsal striatum has two different neuronal cell types: medium spiny projection neurons (MSNs) and interneurons such as cholinergic interneurons (CINs). MSNs consist of direct pathway (dMSNs) and indirect pathway (iMSNs) subclasses. dMSNs express dopamine 1 receptors (D1Rs) and function in promoting movement. In contrast, iMSNs express dopamine 2 receptors (D2Rs) and function in movement inhibition. Alterations in striatal dopamine, as is observed in substance use disorder and Parkinson's disease, bidirectionally modulates dopamine release leading to an imbalance in reversible protein phosphorylation downstream of the dopamine receptors. Serine/threonine protein phosphorylation is mediated by kinases and highly promiscuous phosphatases. Spinophilin is the major postsynaptic density protein phosphatase 1 (PP1) targeting protein. Spinophilin is highly expressed in the striatum and we have found that spinophilin is regulated by, and modulates behavioral impacts of, dopamine on motor outputs. While spinophilin interacts with D2R, but not the D1R, how spinophilin impacts D2R function and subcellular localization in the context of striatal dysfunction is unclear. Given our previous studies, we hypothesize that spinophilin modulates dopamine-dependent motor output by actions on postsynaptic D2R function. Consistent with this hypothesis, we found that global loss of spinophilin led to a tolerance to the locomotive-suppressing effects of D2R agonist, quinpirole (3 mg/kg), a dose found to consistently impair locomotion. Moreover, ongoing studies suggest that loss of spinophilin in iMSNs may recapitulate this effect. Additionally, we have validated a slice biotinylation approach that allows us to measure surface D2R levels. This approach will be used to detail potential mechanisms by which spinophilin mediates quinpirole-induced locomotor sensitization. Together, understanding spinophilin's role in modulating D2R function and subsequent downstream signaling could contribute to potential therapeutic drugs for diseases associated with striatal dysfunction.

The role of Spinophilins interaction with postsynaptic D2R in striatal dysfunction context

Dopamine D2L Receptor Deficiency Alters Neuronal Excitability and Spine Formation in Mouse Striatum

Emerging roles of striatal dopamine D2 receptors in motivated behaviour: Implications for psychiatric disorders

Effects of intrastriatal injection of the dopamine receptor agonist SKF38393 and quinpirole on locomotor behavior in hemiparkinsonism rats

Disentangling the diverse roles of dopamine D2 receptors in striatal function and behavior

Dopaminergic modulation of striatal function and Parkinson’s disease

Dopamine–endocannabinoid Interactions Mediate Spike-Timing-dependent Potentiation in the Striatum

Combinatorial topography and cell-type specific regulation of the ERK pathway by dopaminergic agonists in the mouse striatum

Differential regulation of motor control and response to dopaminergic drugs by D1R and D2R neurons in distinct dorsal striatum subregions

D2 dopamine receptors and the striatopallidal pathway modulate L-DOPA-induced dyskinesia in the mouse

Differential striatal spine pathology in Parkinson's disease and cocaine addiction: a key role of dopamine?

Dichotomous Dopaminergic Control of Striatal Synaptic Plasticity.

Cell- and state-specific plasticity of striatal glutamatergic synapses is critical to the expression of levodopa-induced dyskinesia

The Role of Dopamine in Modulating the Structure and Function of Striatal Circuits

The Role Of Dopaminergic Synapse And D2DR In Movement Control: 3410 Board #231 May 29 2:30 PM - 4:00 PM

Substantia Nigra Pars Reticulata Projections to the Pedunculopontine Nucleus Modulate Dyskinesia

The D2-like Dopamine Receptor Agonist Quinpirole Microinjected Into the Ventral Pallidum Dose-Dependently Inhibits the VTA and Induces Place Aversion

A Dopamine D2 Receptor-Disc1 Protein Complex May Contribute to Antipsychotic-Like Effects.

Striatal cell-type-specific molecular signatures reveal therapeutic targets in a model of dystonia

Unraveling the Differential Functions and Regulation of Striatal Neuron Sub-Populations in Motor Control, Reward, and Motivational Processes

Sulpiride Modulates Striatal Bold Signal During the Manipulation of Information in Working Memory